CD8A and neoplasm: Such a high-efficiency ROS generation during MON-PpIX-LA-CO2–mediated treatment triggered robust ICD of tumor cells, thus promoting the maturation of DCs and activation of effector CD8+ T cells in 4T1 tumor-bearing mouse models.